---
figid: PMC5008054__gr5
figlink: /pmc/articles/PMC5008054/figure/f0025/
number: Fig. 5
caption: 'Illustration of the ILK signaling pathway generated using QIAGEN׳s Ingenuity®Pathway
  Analysis, differentially regulated under GAG interaction conditions. The proteins
  in red and green indicate higher and lower abundance levels under GAG interaction
  conditions, respectively. In addition, the figure also illustrates that TNF-α participates
  in the upstream regulation of this pathway. The arrows indicate predicted regulation,
  activation (→) or inhibition (⊢). The proteins used in this analysis were filtered
  using the following criteria: minimum of 2.0-fold change and quantitation ANOVA,
  p-value ≤ 0.05. ECM protein-extracellular protein; FAK - Focal adhesion kinase;
  PI3K − 1 Phosphatidyl inositol 3 kinase; ILKAP - Integrin-linked kinase-associated
  serine/threonine phosphatase 2C; ILK - Integrin-linked protein kinase; PARVβ- Parvin
  beta; RICTOR - Rapamycin-insensitive companion of mTOR; PXN – Paxilin; VCL – Vinculin;
  Filamin-binding LIM protein 1; KIND2 - Fermitin family homolog 2; TESK1 - Dual specificity
  testis-specific protein kinase 2; PARVα - Parvin alpha; PDK1 − 3-phosphoinositide-dependent
  protein kinase 1; AKT - Protein Kinase B; CASP3 - Caspase-3; PIP3 - Phosphatidylinositol
  (3,4,5)-trisphosphate; PIP2 - phosphatidylinositol biphosphate; PI3K − 1 Phosphatidyl
  inositol 3 kinase; PTEN - Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase
  and dual-specificity protein phosphatase PTEN; IRS - Insulin receptor substrate;
  PINCH - LIM and senescent cell antigen-like-containing domain protein; TB4 - Thymosin
  beta-4; RSU1 - Ras suppressor protein 1; RTK - Receptor tyrosine kinase; PP2A -
  Protein phosphatase 2A; NCK2 - Cytoplasmic protein NCK2; DOCK 180 - Dedicator of
  cytokinesis protein 180; TNFR - tumor necrosis factor receptor; GSK3 - Glycogen
  synthase kinase-3; JNK - c-Jun N-terminal Protein Kinase; mTOR - Serine/threonine-protein
  kinase mTOR; NACA - Nascent polypeptide-associated complex subunit alpha; ERK 1/2
  - Mitogen-activated protein kinase ERK 1/2; CTNNβ - Catenin (Cadherin-Associated
  Protein), Beta; MSK 1/2 - Mitogen and stress activated protein kinase 1/2; CREB
  - Cyclic AMP-responsive element-binding protein; LEF 1- Lymphoid enhancer-binding
  factor 1; cJUN – Jun Proto-Oncogene; cFOS – FBJ Murine Osteosarcoma viral oncogene
  homolog; HIF 1α - Hypoxia-inducible factor 1-alpha; c-MYC - Myc proto-oncogene protein;
  iNOS - Nitric oxide synthase, inducible; COX2 - Prostaglandin G/H synthase 2; MMP9
  - Matrix metalloproteinase-9; VEGF - Vascular endothelial growth factor; SLUG -
  Zinc finger protein SNAI2; FN1 – Fibronectin; RHO - Ras-like GTP-binding protein
  Rho; DSP – Desmoplakin; KRT 18 - Keratin, type I cytoskeletal 18; MUC – Mucin; VIM
  – Vimentin. (For interpretation of the references to color in this figure legend,
  the reader is referred to the web version of this article).'
pmcid: PMC5008054
papertitle: Dataset of differentially regulated proteins in HUVECs challenged with
  wild type and UGM1 mutant Aspergillus fumigatus strains.
reftext: Gabriela Westerlund Peixoto Neves, et al. Data Brief. 2016 Dec;9:24-31.
pmc_ranked_result_index: '234219'
pathway_score: 0.8689099
filename: gr5.jpg
figtitle: Illustration of the ILK signaling pathway generated using QIAGEN׳s Ingenuity®Pathway
  Analysis, differentially regulated under GAG interaction conditions
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5008054__gr5.html
  '@type': Dataset
  description: 'Illustration of the ILK signaling pathway generated using QIAGEN׳s
    Ingenuity®Pathway Analysis, differentially regulated under GAG interaction conditions.
    The proteins in red and green indicate higher and lower abundance levels under
    GAG interaction conditions, respectively. In addition, the figure also illustrates
    that TNF-α participates in the upstream regulation of this pathway. The arrows
    indicate predicted regulation, activation (→) or inhibition (⊢). The proteins
    used in this analysis were filtered using the following criteria: minimum of 2.0-fold
    change and quantitation ANOVA, p-value ≤ 0.05. ECM protein-extracellular protein;
    FAK - Focal adhesion kinase; PI3K − 1 Phosphatidyl inositol 3 kinase; ILKAP -
    Integrin-linked kinase-associated serine/threonine phosphatase 2C; ILK - Integrin-linked
    protein kinase; PARVβ- Parvin beta; RICTOR - Rapamycin-insensitive companion of
    mTOR; PXN – Paxilin; VCL – Vinculin; Filamin-binding LIM protein 1; KIND2 - Fermitin
    family homolog 2; TESK1 - Dual specificity testis-specific protein kinase 2; PARVα
    - Parvin alpha; PDK1 − 3-phosphoinositide-dependent protein kinase 1; AKT - Protein
    Kinase B; CASP3 - Caspase-3; PIP3 - Phosphatidylinositol (3,4,5)-trisphosphate;
    PIP2 - phosphatidylinositol biphosphate; PI3K − 1 Phosphatidyl inositol 3 kinase;
    PTEN - Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity
    protein phosphatase PTEN; IRS - Insulin receptor substrate; PINCH - LIM and senescent
    cell antigen-like-containing domain protein; TB4 - Thymosin beta-4; RSU1 - Ras
    suppressor protein 1; RTK - Receptor tyrosine kinase; PP2A - Protein phosphatase
    2A; NCK2 - Cytoplasmic protein NCK2; DOCK 180 - Dedicator of cytokinesis protein
    180; TNFR - tumor necrosis factor receptor; GSK3 - Glycogen synthase kinase-3;
    JNK - c-Jun N-terminal Protein Kinase; mTOR - Serine/threonine-protein kinase
    mTOR; NACA - Nascent polypeptide-associated complex subunit alpha; ERK 1/2 - Mitogen-activated
    protein kinase ERK 1/2; CTNNβ - Catenin (Cadherin-Associated Protein), Beta; MSK
    1/2 - Mitogen and stress activated protein kinase 1/2; CREB - Cyclic AMP-responsive
    element-binding protein; LEF 1- Lymphoid enhancer-binding factor 1; cJUN – Jun
    Proto-Oncogene; cFOS – FBJ Murine Osteosarcoma viral oncogene homolog; HIF 1α
    - Hypoxia-inducible factor 1-alpha; c-MYC - Myc proto-oncogene protein; iNOS -
    Nitric oxide synthase, inducible; COX2 - Prostaglandin G/H synthase 2; MMP9 -
    Matrix metalloproteinase-9; VEGF - Vascular endothelial growth factor; SLUG -
    Zinc finger protein SNAI2; FN1 – Fibronectin; RHO - Ras-like GTP-binding protein
    Rho; DSP – Desmoplakin; KRT 18 - Keratin, type I cytoskeletal 18; MUC – Mucin;
    VIM – Vimentin. (For interpretation of the references to color in this figure
    legend, the reader is referred to the web version of this article).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRT1
  - RICTOR
  - SLC7A1
genes:
- word: KRT1
  symbol: KRT1
  source: hgnc_symbol
  hgnc_symbol: KRT1
  entrez: '3848'
- word: RÍCTOR
  symbol: RICTOR
  source: hgnc_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: ERR
  symbol: ERR
  source: hgnc_prev_symbol
  hgnc_symbol: SLC7A1
  entrez: '6541'
chemicals: []
diseases: []
---
